Table 3 HAV and HBV vaccination and immune status.
From: Hepatitis A and hepatitis B infection risk among employees at schools for disabled pupils
N | HAV vaccination | HBV vaccination | Undergone HAV (p*) | Undergone HBV (p*) | ||
|---|---|---|---|---|---|---|
Age | 20–29 J | 123 | 72%a (p = 0.001) | 81%a (p = 0.000) | 0% (p = 0.142; pFi = 0.251) | 1% (p = 0.717; pFi = 1.000) |
30–44 J | 525 | 62% | 67% | 0% | < 1% | |
≥ 45 J | 750 | 53%b (p = 0.000) | 60% (p = 0.000) | 3% (p = 0.000; pFI = 0.000) | 2% (p = 0.026; pFI = 0.040) | |
Gender | Female | 1161 | 59% (p = 0.046) | 66% (p = 0.004) | 2% (p = 0.467; pFi = 0.403) | 1% (p = 0.633; pFi = 1.000) |
Male | 237 | 52% | 56% | 2% | 1% | |
Profession1 | ES | 849 | 60% (p = 0.062) | 67% (p = 0.014) | 2% (p = 0.013) | 2% (p = 0.092) |
TS | 547 | 55% | 60%* | 1% | 1% | |
Support focus | M/P | 943 | 65% (p = 0.000) | 71% (p = 0.000) | 2% (p = 0.941) | 1% (p = 0.517) |
ES/IF | 455 | 44% | 50% | 2% | 1% |
